Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 132
- CBD Market
DEA classifies novel cannabinoids Delta-8 and -9 THCO as controlled substances
CONTROLLED SUBSTANCES DEA classifies novel cannabinoids Delta-8 and -9 THCO as controlled substances Marijuana Moment reports that, as Delta-8 and -9 THCO do not meet the federal definition of legal hemp, the DEA has now confirmed they are considered illegal controlled substances.
- Press releases
Parents, Scientists Back New Study Into Benefits Of Medical Cannabis For Children With Severe Epilepsy
PRESS RELEASE On Monday February 13, International Epilepsy Day, MedCan Support, Drug Science and Alta Flora announced the launch of a next-generation digital observational study, for children with epilepsy who are prescribed cannabis oil.
- Press releases
Kanabo Group Publishes Business Update
PRESS RELEASE KANABO Group plc (LSE: KNB), a leading patient-focused HealthTech ecosystem, uniquely combining innovative technology solutions and personalised medical treatments, provides the following business update.
- Medical
France Reports Highly Positive Patient Response To Medical Cannabis Trial, But Results Unlikely To Impact Decision To Legalise
FRANCE’s ongoing medical cannabis ‘experiment’, in which 3,000 patients are offered free products, has reported an overwhelmingly positive patient response.
- Data & Analysis
Predictions for global cannabis trends in 2023
CANNABIS TRENDS FOR 2023 Predictions for global cannabis trends in 2023 Writing for The Rolling Stone, Andrew Wilson explores some of his predicted trends for the cannabis industry in 2023.
- Opinion
MHRA Clarification Is A Step In The Right Direction, Says CIC
IN November 2022, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) released new detailed guidelines for medical cannabis companies operating in the UK, providing a step-by-step plan for those ‘that do not already hold the necessary authorisations’ to begin producing cannabis-based medicinal products and APIs.
- CBD Market
Canopy Growth cuts 800 jobs at flagship facility
CANOPY GROWTH JOB CUTS Canopy Growth cuts 800 jobs at flagship facility Canopy Growth is closing its flagship cultivation facility in Smiths Falls, Ontario, and cutting more than a third of its workforce as part of a shift to an “asset-light model” in Canada, reports MJ Biz Daily.
- Markets & Stocks
Love Hemp Becomes First Cannabis Casualty Of 2023 As It Calls In Administrators & Akanda’s CEO Tej Virk Resigns
Love Hemp BusinessCann has learned that the embattled CBD retailer Love Hemp has officially called in administrators.
- CBD Market
Ohio senators take up bill to overhaul state’s medical cannabis program
OHIO MEDICAL CANNABIS Ohio senators take up bill to overhaul state’s medical cannabis program Ohio senators are trying once more to overhaul the state’s medical cannabis system, whilst a bid to place recreational use on the ballot has gained steam, reports Marijuana Moment.
- Press releases
Treasury Should “Unlock” Cannabis Economic Benefits, Says CIC
PRESS RELEASE THE Treasury has been urged to ”unlock the very significant economic potential” of the medical cannabis, hemp, and CBD wellbeing sectors by the Cannabis Industry Council (CIC).
- CBD Market
Cannaray’s £18.6m RTO Deal With Cellular Goods Scrapped Over ‘Decrease In Share Price’
YESTERDAY morning Cellular Goods informed investors that its proposed £18.6m reverse-takeover deal with Cannaray has been scrapped.
- Markets & Stocks
Could California bring the US closer to interstate cannabis commerce?
CANNABIS EXPORT Could California bring the US closer to interstate cannabis commerce?












